Protocol for treatment and research of acute lymphoblastic leukaemia of childhood of the Dutch childhood oncology group

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN21542083

Enrollment

918

Registered

2007-02-28

Start date

1997-01-01

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lymphoblastic Leukaemia (ALL) Cancer Leukaemia

Interventions

Stratification into standard risk and high risk.

Eligibility

Inclusion criteria

Inclusion criteria: All children with acute lymphoblastic leukaemia from one year (365 days) until 18 years of age, excluding mature B-cell ALL.

Exclusion criteria

Exclusion criteria: 1. Mature B-cell ALL 2. Relapsed ALL 3. Secondary ALL 4. Pretreatment with corticosteroids or cytostatic drugs in the four weeks preceding diagnosis 5. Patient of whom essential diagnostic tests are missing 6. Patients in whom essential parts of therapy were not given

Design outcomes

Primary

Measure	Time frame
Survival	—

Secondary

Measure	Time frame
Event free survival	—

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026